Efficacy of lipid-lowering therapy beyond statins to prevent cardiovascular events: a meta-analysis

被引：4
|
作者：
Dykun, Iryna [1 ]
Mincu, Raluca [1 ]
Hendricks, Stefanie [1 ]
Balcer, Bastian [1 ]
Totzeck, Matthias [1 ]
Rassaf, Tienush [1 ]
Mahabadi, Amir A. [1 ]
机构：
[1] Univ Duisburg Essen, Dept Cardiol & Vasc Med, Essen, Germany
来源：
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2020年 / 27卷 / 15期
关键词：
REDUCING LIPIDS; SAFETY; EZETIMIBE;
D O I：
10.1177/2047487319866992
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1675 / 1678
页数：4
相关论文
共 50 条
  • [31] Frontiers in Lipid Lowering Therapy: To Statins and Beyond
    Chaudhuri, Arindam
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2020, 60 (06) : 798 - 799
  • [32] The efficacy of intensive lipid-lowering therapies on the reduction of LDLc and of major cardiovascular events
    Cordero, Alberto
    Olmo, Rosa Fernandez
    Badimon, Lina
    Santos-Gallego, Carlos G.
    Castellano, Jose M.
    Facila, Lorenzo
    Rodriguez-Manero, Moises
    Bonanad, Clara
    Vilahur, Gemma
    Escribano, David
    Badimon, Juan J.
    Gonzalez-Juanatey, Jose R.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2023, 17 (05) : 602 - 611
  • [33] The upfront lipid-lowering combination therapy of statins and ezetimibe vs statin monotherapy in the reduction of cardiovascular outcomes. A meta-analysis.
    Banach, M.
    Jaiswal, V
    Ang, S. P.
    Sawhney, A.
    Deb, N.
    Penson, P.
    Toth, P.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [34] Efficacy and safety of bempedoic acid lipid-lowering therapy: a systematic review and meta-analysis of randomized controlled trials
    Venkatraman, Shravan
    Das, Saibal
    Eerike, Madhavi
    Cherian, Jerin Jose
    Bagepally, Bhavani Shankara
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (11) : 1453 - 1463
  • [35] Efficacy and safety of bempedoic acid lipid-lowering therapy: a systematic review and meta-analysis of randomized controlled trials
    Shravan Venkatraman
    Saibal Das
    Madhavi Eerike
    Jerin Jose Cherian
    Bhavani Shankara Bagepally
    European Journal of Clinical Pharmacology, 2023, 79 : 1453 - 1463
  • [36] Lipid-lowering therapy and risk of coronary events
    Blakely, JA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (16): : 2070 - 2071
  • [37] Lipid-lowering therapy - New and established agents reduce risk of cardiovascular events
    Smith, CR
    POSTGRADUATE MEDICINE, 2004, 115 (03) : 29 - +
  • [38] Cardiovascular risk and lipid-lowering drug therapy
    Stulnig, T.
    DIABETOLOGE, 2012, 8 (07): : 568 - 572
  • [39] Lipid-Lowering Therapy in Persons With Chronic Kidney Disease A Systematic Review and Meta-analysis
    Upadhyay, Ashish
    Earley, Amy
    Lamont, Jenny L.
    Haynes, Shana
    Wanner, Christoph
    Balk, Ethan M.
    ANNALS OF INTERNAL MEDICINE, 2012, 157 (04) : 251 - +
  • [40] The effects of lipid-lowering therapy on coronary plaque regression: a systematic review and meta-analysis
    Yingrui Li
    Songbai Deng
    Bin Liu
    Yulin Yan
    Jianlin Du
    Yu Li
    Xiaodong Jing
    Yajie Liu
    Jing Wang
    Jun Du
    Qiang She
    Scientific Reports, 11
12345